APA (7th ed.) Citation

Macbeth, F., Griffiths, G., Noble, S., Burns, S., & Maughan, T. (2009). Interim safety data on the FRAGMATIC trial: A randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer.

Chicago Style (17th ed.) Citation

Macbeth, F., G. Griffiths, S. Noble, S. Burns, and T. Maughan. Interim Safety Data on the FRAGMATIC Trial: A Randomised Phase III Clinical Trial Investigating the Effect of FRAGMin (R) Added to Standard Therapy in Patients with Lung Cancer. 2009.

MLA (9th ed.) Citation

Macbeth, F., et al. Interim Safety Data on the FRAGMATIC Trial: A Randomised Phase III Clinical Trial Investigating the Effect of FRAGMin (R) Added to Standard Therapy in Patients with Lung Cancer. 2009.